Sökning: onr:"swepub:oai:prod.swepub.kib.ki.se:130165034" > Interferon beta tre...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 02728naa a2200349 4500 | |
001 | oai:prod.swepub.kib.ki.se:130165034 | |
003 | SwePub | |
008 | 240913s2014 | |||||||||||000 ||eng| | |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1301650342 URI |
024 | 7 | a https://doi.org/10.1177/13524585145327002 DOI |
040 | a (SwePub)ki | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Lundstrom, W4 aut |
245 | 1 0 | a Interferon beta treatment of multiple sclerosis increases serum interleukin-7 |
264 | c 2014-05-12 | |
264 | 1 | b SAGE Publications,c 2014 |
520 | a Interleukin-7 (IL-7) is a non-redundant cytokine for T-cell development and survival. The IL-7 signaling pathway has been genetically and functionally associated with several autoimmune diseases including multiple sclerosis (MS). Objective: The objective of this paper is to elucidate the effect of the widely used immunomodulatory MS therapy interferon beta (IFNβ) on IL-7 homeostasis. Methods: Swedish MS patients were screened for IL-7 concentration in serum and blood cell counts. IL-7 receptor alpha chain (IL-7Rα) expression was determined by semi-quantitative real-time polymerase chain reaction (PCR) and flow cytometry. Results: IFNβ treatment led to significantly increased serum IL-7 levels (mean: 17 pg/ml) compared with healthy controls (mean: 7.6 pg/ml) and natalizumab-treated patients (mean: 5.3 pg/ml). In vitro and in vivo, peripheral blood leukocytes showed decreased IL-7Rα expression and IL-7 consumption upon IFNβ exposure, suggesting that their IL-7 responsiveness is impaired during treatment. Conclusions: MS patients undergoing IFNβ treatment have increased serum IL-7 levels and decreased IL-7 consumption. Given IL-7’s important role in T-cell immunity, this relationship may be highly relevant for IFNβ’s treatment efficacy. | |
700 | 1 | a Hermanrud, Cu Karolinska Institutet4 aut |
700 | 1 | a Sjostrand, Mu Karolinska Institutet4 aut |
700 | 1 | a Brauner, Su Karolinska Institutet4 aut |
700 | 1 | a Wahren-Herlenius, Mu Karolinska Institutet4 aut |
700 | 1 | a Olsson, Tu Karolinska Institutet4 aut |
700 | 1 | a Karrenbauer, Vu Karolinska Institutet4 aut |
700 | 1 | a Hillert, Ju Karolinska Institutet4 aut |
700 | 1 | a Fogdell-Hahn, Au Karolinska Institutet4 aut |
710 | 2 | a Karolinska Institutet4 org |
773 | 0 | t Multiple sclerosis (Houndmills, Basingstoke, England)d : SAGE Publicationsg 20:13, s. 1727-1736q 20:13<1727-1736x 1477-0970x 1352-4585 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:130165034 |
856 | 4 8 | u https://doi.org/10.1177/1352458514532700 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy